TAKC-02

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameTAKC-02
Drug Alias NameTAKC-02
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionRNA-binding protein MEX3B inhibitors
TargetsRNA-binding protein MEX3B
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesTAK Circulator Co
China Registration ClassN/A

Develop Information

Active CompaniesTAK Circulator Co
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A